InnovAge (NASDAQ:INNV) Stock Price Down 7.1% – Here’s Why

InnovAge Holding Corp. (NASDAQ:INNV – Get Free Report) shares were down 7.1% on Thursday. The company traded as low as $8.42 and last traded at $8.2750. Approximately 71,693 shares were traded during mid-day trading, a decline of 81% from the average session volume of 385,207 shares. The stock had previously closed at $8.91.

Analyst Ratings Changes

Several analysts have recently issued reports on INNV shares. KeyCorp boosted their price objective on shares of InnovAge from $13.00 to $14.00 and gave the company an “overweight” rating in a research note on Wednesday, September 9th. Weiss Ratings raised InnovAge from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, November 4th. Wall Street Zen upgraded InnovAge from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 7th. Finally, Zacks Research upgraded InnovAge from a “hold” rating to a “strong-buy” rating in a report on Monday, November 16th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $10.50.

Read Our Latest Report on InnovAge

InnovAge Stock Performance

The stock’s 50-day moving average is $9.36 and its 200-day moving average is $9.30. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of 153.00 and a beta of 0.16. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.20.

InnovAge (NASDAQ:INNV – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.09 by $0.05. The firm had revenue of $264.76 million for the quarter, compared to analyst estimates of $257.23 million. InnovAge had a net margin of 0.88% and a return on equity of 3.63%. On average, analysts expect that InnovAge Holding Corp. will post 0.44 EPS for the current year.

Insider Transactions at InnovAge

In other news, insider Nicole Damato sold 3,402 shares of the stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $9.51, for a total value of $32,353.02. Following the completion of the sale, the insider owned 301,495 shares of the company’s stock, valued at $2,867,217.45. This represents a 1.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Carson Anderson & Stow Welsh sold 1,500,000 shares of the firm’s stock in a transaction on Wednesday, October 21st. The shares were sold at an average price of $9.25, for a total transaction of $13,875,000.00. Following the completion of the transaction, the insider directly owned 101,076,555 shares in the company, valued at approximately $934,958,133.75. This represents a 1.46% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 13,027,216 shares of company stock valued at $120,489,535 over the last 90 days. Corporate insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Legal & General Group Plc purchased a new stake in shares of InnovAge in the second quarter worth about $25,000. Aquatic Capital Management LLC purchased a new stake in shares of InnovAge during the 3rd quarter valued at about $100,000. Polymer Capital Management US LLC purchased a new stake in shares of InnovAge during the 3rd quarter valued at about $105,000. NewEdge Advisors LLC acquired a new position in InnovAge during the 2nd quarter worth approximately $142,000. Finally, Virtus Advisers LLC acquired a new position in InnovAge during the 2nd quarter worth approximately $207,000. Institutional investors and hedge funds own 12.26% of the company’s stock.

InnovAge Company Profile

(Get Free Report)

InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.

Further Reading

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.